Pharmaceutical company
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regarding the Independent Payment Advisory Board (IPAB) deadline and potential repeal. Education regarding Center for Medicare and Medicaid Innovation (CMMI) program and potential safeguards.  Monitoring developments regarding Part B and Part D programs.  Monitoring vaccine policy developments.  Education regarding prescription Drug User Fee Act (PDUFA).
TAX - Taxation/Internal Revenue Code HCR - Health Issues
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 41 - Treasury, Dept of 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 198 - Natl Economic Council (NEC) 1 - SENATE 41 - Treasury, Dept of
ADVANCED POLICY CONSULTING, LLC
2503-D Harrison Street North #1210, Arlington, VA, 22207, US
MATTHEW MCGINLEY MATTHEW MCGINLEY